STAT3 and squamous cell carcinoma: Atorvastatin-treated squamous cell carcinoma cell lines, derived from head and neck cancers involving the floor of the mouth and tongue, demonstrated a significant inhibition of phosphorylated STAT3 in connection with reduced metastatic potential [48].